Assertion / Strategy		B-RAF inhibition	B-RAF inhibition + MEK inhibition	EGFR inhibition	PARP inhibition	PD-1/PD-L1 inhibition	PDGF-R inhibition	PRMT5 inhibition	Thymidylate synthase inhibition
therapy_sensitivity			Dabrafenib + Trametinib		Talazoparib	Pembrolizumab	Imatinib	EPZ015666	
therapy_resistance		Vemurafenib		Panitumumab					5-Fluorouracil
